Otten J D, van Dijck J A, Peer P G, Straatman H, Verbeek A L, Mravunac M, Hendriks J H, Holland R
Department of Epidemiology, University of Nijmegen, Netherlands.
J Epidemiol Community Health. 1996 Jun;50(3):353-8. doi: 10.1136/jech.50.3.353.
To assess the performance of breast cancer screening in different age categories over two decades.
Important determinants of reduced breast cancer mortality such as attendance, mammography performance, cancer detection, and disease stage were recorded.
Nijmegen, The Netherlands, 1975-92.
Since 1975 more than 40,000 women aged 35 years and older have been invited biennially for breast screening in a population based project in Nijmegen.
Rates of attendance, referral, detection, and disease stage were calculated, as well as the specificity of screening mammography and the predictive value of referral and biopsy. From round 3 onwards, the attendance rate of women younger than 50 years stabilised at 70%, in women of 50-69 years it was 62%, and in women aged 70 and over it was 22%. In these three age categories, the referral rates of a positive screening mammography per 1000 screened women were 4.9, 6.2, and 11.8, respectively. Specificity rates were between 99% and 100%. Current predictive values of referral were high: in the specific age categories 39%, 59%, and 68% of the referred women had cancer. Detection rates remained fairly stable over the rounds 4-9, at 1.9, 3.6, and 8.0 cancers per 1000 screened women. In the two year period between screening the numbers of interval cancers per 1000 screened women were 2.2, 2.2, and 2.9, for the three age categories respectively. With regard to invasive cancers detected during screening, the percentage of small tumours (< or = 20 mm on the mammogram) was 84% in each age category. For women younger than 50 years, the proportion of intraductal carcinoma in all the cancers detected at screening was 40%, while it was 15% in the other age categories.
Throughout the nine rounds, the screening outcomes were found to be adequate, particularly considering the high specificity rate and the predictive value of referral without the interference of a low detection rate. Although the occurrence of interval cancers seemed high, it was similar to other screening programmes. Despite a relatively low referral rate, the ratios of screen detected versus interval cancer cases were favourable. Well organised screening programmes can achieve good mammography results without too many false positives. It is important that women continue to participate in a screening programme because cancer can still be detected even after several successive negative screening examinations.
评估二十年间不同年龄组乳腺癌筛查的效果。
记录了诸如参与率、乳房X线摄影表现、癌症检出率和疾病阶段等对降低乳腺癌死亡率有重要影响的因素。
荷兰奈梅亨,1975年至1992年。
自1975年以来,奈梅亨一项基于人群的项目每两年邀请40000多名35岁及以上的女性进行乳房筛查。
计算了参与率、转诊率、检出率和疾病阶段,以及乳房X线筛查的特异性、转诊和活检的预测价值。从第3轮开始,50岁以下女性的参与率稳定在70%,50至69岁女性为62%,70岁及以上女性为22%。在这三个年龄组中,每1000名接受筛查的女性中,乳房X线筛查呈阳性的转诊率分别为4.9、6.2和11.8。特异性率在99%至100%之间。目前转诊的预测价值较高:在特定年龄组中,转诊女性患癌症的比例分别为39%、59%和68%。在第4至9轮中,检出率保持相当稳定,每1000名接受筛查的女性中分别有1.9、3.6和8.0例癌症。在两次筛查之间的两年时间里,每1000名接受筛查的女性中的间期癌数量分别为2.2、2.2和2.9例,对应三个年龄组。对于筛查期间检测到的浸润性癌症,每个年龄组中小肿瘤(乳房X线片上≤20毫米)的比例为84%。对于50岁以下的女性,筛查时检测到的所有癌症中导管内癌的比例为40%,而在其他年龄组中为15%。
在整个九轮筛查中,筛查结果被认为是充分的,特别是考虑到高特异性率和转诊的预测价值,且没有低检出率的干扰。尽管间期癌的发生率似乎较高,但与其他筛查项目相似。尽管转诊率相对较低,但筛查发现的癌症病例与间期癌病例的比例是有利的。组织良好的筛查项目可以在不过多出现假阳性的情况下取得良好的乳房X线摄影结果。重要的是女性要继续参与筛查项目,因为即使经过几次连续的阴性筛查检查后仍能检测到癌症。